Last reviewed · How we verify
NCT05490862
Inflammatory Status of Monocytes in Obesity
NA trial testing Lifestyle Modification in Obesity in 100 participants. Status unknown.
1 September 2023
Quick facts
| Lead sponsor | Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 100 |
| Start date | 11 January 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 14 December 2023 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Lifestyle Modification
- Traditional Recommendations
Conditions studied
- Obesity — all drugs for Obesity →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Who can join
Adults 50 to 80, any sex, with Obesity or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study of the pro-inflammatory activation of circulating monocytes/macrophages in obesity is the main problem of this project. The investigation of pro-inflammatory activation of monocytes and determination of the level of mitochondrial genome mutations, assessment of traditional CVD risk factors and the degree of cardiovascular risk and atherosclerosis indicators and their association will be investigated in dynamics on 12-weeks weight loss.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05490862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle Modification
Trials testing the same drug.
- NCT07393412 — Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: · not yet recruiting
- NCT06477146 — Milk Thistle Clinical Trial in Pediatric NAFLD · Phase 2 · recruiting
- NCT06417684 — Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine · EARLY_PHASE1 · withdrawn
- NCT05515978 — Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients · EARLY_PHASE1 · recruiting
- NCT03922945 — A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity · Phase 4 · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology trials
Trials by the same sponsor.
- NCT06727279 — Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profi · NA · not yet recruiting
- NCT07121803 — The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility · NA · recruiting
- NCT06724913 — Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice C · NA · active not recruiting
- NCT05543811 — The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyri · NA · completed
- NCT05224037 — Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05490862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
- Last refreshed: 6 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05490862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing